In a move sure to spur copycat actions, Eli Lilly will become the first drug manufacturer to disclose voluntarily all payments made to physicians that exceed $500. This includes payments for speeches, conference attendance, advice and other services. Eventually, Lilly advises, it will disclose payments made to physicians for travel, entertainment, and gifts. The disclosures will begin in the second half of 2009 and will include payments made during the first half of 2009. In 2011, Lilly will begin disclosing payments made for clinical research, patterned after the Physician Payments Sunshine Act (H.R. 5606, S. 2029), currently pending in Congress